[1]Sun XW, Wei J, Yang Z, et al. Clinical Features and Prognosis of Crohn¡¯s Disease with Upper Gastrointestinal Tract Phenotype in Chinese Patients[J]. Dig Dis Sci,2019, 64(11): 3291-3299.
[2]Laube R, Liu K, Schifter M, et al. Oral and upper gastrointestinal Crohn¡¯s disease[J]. J Gastroenterol Hepatol, 2018,3(2):355-364.
[3]Öìΰ˼. ÉÏÏû»¯µÀ¿ËÂÞ¶÷²¡ÁÙ´²ÌØÕ÷¼°ÕïÁÆÏÖ×´·ÖÎö[D]. ¹ãÖÝ£ºÄÏ·½Ò½¿Æ´óѧ, 2015.
[4]Pimentel AM,Rocha R,Santana GO, et al. Crohn¡¯s disease of esophagus, stomach and duodenum[J]. World J Gastrointest Pharmacol Ther, 2019,10(2): 35-49.
[5]Tan CX, Brand HS, de Boer NK, et al.Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn¡¯s disease[J]. Br Dent J, 2016,221(12): 794-799.
[6]Tan CXW,de Boer NKH,Brand HS, et al. Oral manifestations of Crohn¡¯s disease[J]. Ned Tijdschr Tandheelkd, 2018, 125(1): 15-20.
[7]Schwartzberg DM,Brandstetter S,Grucela AL, et al. Crohn¡¯s Disease of the Esophagus, Duodenum, and Stomach[J]. Clin Colon Rectal Surg, 2019,32(4): 231-242.
[8]Davis KG. Crohn¡¯s Disease of the Foregut[J]. Surg Clin North Am, 2015,95(6): 1183-1193.
[9]Greuter T, Piller A,Fournier N, et al. Upper Gastrointestinal Tract Involvement in Crohn¡¯s Disease: Frequency, Risk Factors, and Disease Course[J]. J Crohns Colitis, 2018, 12(12): 1399-1409.
[10]De Felice KM, Katzka DA, Raffals LE. Crohn s Disease of the Esophagus:Crohn¡¯s Disease of the Esophagus: Clinical Features and Treatment Outcomes in the Biologic Era[J]. Inflamm Bowel Dis, 2015,21(9): 2106-2113.
[11]Nomura Y, Moriichi K, Fujiya M, et al. The endoscopic findings of the upper gastrointestinal tract in patients with Crohn¡¯s disease[J]. Clin J Gastroenterol, 2017,10(4): 289-296.
[12]Singh A,Agrawal N,Kurada S,et al. Efficacy, Safety, and Long-term Outcome of Serial Endoscopic Balloon Dilation for Upper Gastrointestinal Crohn¡¯s Disease-associated Strictures-A Cohort Study[J]. J Crohns Colitis, 2017, 11(9):1044-1051.
[13]Sato Y,Matsui T,Yano Y,et al. Long-term course of Crohn¡¯s disease in Japan: Incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery[J]. J. Gastroenterol Hepatol,2015,30(12):1713-1719.
[14]Lightner AL,Fletcher JG. Duodenal Crohn¡¯s Disease-a Diagnostic Conundrum[J]. J Gastrointest Surg, 2018,22(4):761-763.
[15]Ooi CJ,Makharia GK,Hilmi I,et al. Asia Pacific Consensus Statements on Crohn¡¯s disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn¡¯s Disease Consensus--Part 1)[J]. J Gastroenterol Hepatol, 2016,31:45-55.
[16]Mentzer A,Nayee S,Omar Y,et al. Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial Granulomatosis[J]. Inflamm Bowel Dis, 2016,22:1552-1558.
[17]Farkas K, Chan H, Rutka M, et al. Gastroduodenal involvement in asymptomatic Crohn¡¯s Disease patients in two areas of emerging disease: Asia and Eastern Europe[J]. J Crohns Colitis,2016, 10(12): 1401-1406.
[18]Grand D, Guglielmo F, Al-Hawary M. MR enterography in Crohn¡¯s Disease: current consensus on optimal imaging technique and future advances from the SAR Crohn¡¯s Disease-focused pannel[J]. Abdom Imaging, 2015,40:953-964.
[19]Ooi C, Makharia G, Hilmi I, et al. Asia-Pacific consensus statements on Crohn¡¯s disease. Part 2: Management[J]. J Gastroenterol Hepatol, 2016,31:56-68.
[20]Îâ»ÛÃô£¬Íô·¼Ô£.µ°°×øÓë×ÔÉíÏû»¯ÔÚÑ×Ö¢ÐÔ³¦²¡·¢Éú»úÖÆÖеÄ×÷ÓÃÓëÆôʾ[J]. ҽѧÑо¿Éúѧ±¨,2019,32(6):561-565.
[21]D¥hbkowski K,Graca-Pakulska K,Zawada I,et al. Clinical significance of endoscopic findings in the upper gastrointestinal tract in Crohn¡¯s disease[J]. Scand J Gastroenterol,2019, 54(9): 1075-1080.
[22]Ó¡ÖÐÅô£¬ËÎÁîÐÛ£¬ÍõËÕÃΣ¬µÈ. Ѫ½¬¿¹ÄýѪø¢óºÍѪÇåIL-6Óë½µ¸ÆËØÔ¶ÔÅжϿËÂÞ¶÷²¡»î¶¯ÐÔµÄÁÙ´²¼ÛÖµ[J]. ¶«ÄϹú·ÀÒ½Ò©, 2018, 20(1): 22-25.
[23]¸ß´³£¬¶ÅÏþ²©£¬Íõµ¤µ¤£¬µÈ. °×ϸ°û½éËØ22ÓëÑ×Ö¢ÐÔ³¦²¡µÄÑо¿½øÕ¹[J]. ҽѧÑо¿Éúѧ±¨, 2018, 31(11): 1196-1200.
[24]Cazacu SM,Ghilu ÿðþ ‰D i MC,Ivan ET,et al. An unusual onset of Crohn¡¯s disease with oral aphthosis, giant esophageal ulcers and serological markers of cytomegalovirus and herpes virus infection: a case report and review of the literature.[J]. Rom J Morphol Embryol, 2019, 60(2): 659-665.
[25]Bettenworth D,M¨¹cke MM,Lopez R,et al. Efficacy of Endoscopic Dilation of Gastroduodenal Crohn¡¯s Disease Strictures: A Systematic Review and Meta-Analysis of Individual Patient Data.[J]. Clin Gastroenterol Hepatol,2019,17(12): 2514-2522.
[26]Iborra M,Juli¨¢ B,Mart¨ªn Arranz MD,et al. Management and outcomes of patients with Crohn¡¯s disease with first vs multiple surgeries: results from the PRACTICROHN study[J]. Gastroenterol Rep, 2019, 7(6): 411-418.
[1]Ѧ ËÉ,κ ÀÚ,³Ì ÎÄ,µÈ.¿ËÂÞ¶÷²¡°òë×ðü3Àý±¨¸æ[J].ҽѧÑо¿ÓëÕ½´´É˾ÈÖÎ(ÔҽѧÑо¿Éúѧ±¨),2013,15(01):64.
[2]Íõçæ,Ðì½ðÖÐ,»ÆÓ´º,µÈ.Íâ¿Æ¼ÓËÙ¿µ¸´ÍŶÓÔÚ»¤Àí¿ËÂÞ¶÷²¡»¼ÕßÖеÄÓ¦ÓÃÓëЧ¹û¹Û²ì[J].ҽѧÑо¿ÓëÕ½´´É˾ÈÖÎ(ÔҽѧÑо¿Éúѧ±¨),2017,19(03):311.[doi:10.3969/j.issn.1672-271X.2017.03.023]
[3]Ó¡ÖÐÅô,ËÎÁîÐÛ,ÍõËÕÃÎ,µÈ.Ѫ½¬¿¹ÄýѪø¢óºÍѪÇåIL-6Óë½µ¸ÆËØÔ¶ÔÅжϿËÂÞ¶÷²¡»î¶¯ÐÔµÄÁÙ´²¼ÛÖµ[J].ҽѧÑо¿ÓëÕ½´´É˾ÈÖÎ(ÔҽѧÑо¿Éúѧ±¨),2018,20(01):22.[doi:10.3969/j.issn.1672-271X.2018.01.005]
¡¡YIN Zhong-peng,SONG Ling-xiong,WANG Su-meng,et al.Clinical value of plasma AT-¢ó and serum PCT, IL-6 levels and the evaluations of disease activity in Crohn¡äs disease[J].JOURNAL OF MEDICALRESEARCH ¡ªCOMBAT TRAUMA CARE,2018,20(4):22.[doi:10.3969/j.issn.1672-271X.2018.01.005]
[4]·îæº,κ¾ê,Íô·¼Ô£.¿ËÂÞ¶÷²¡ºÏ²¢¸¹ÅèǻŧÖ×µÄÄÚ¿ÆÖÎÁƽøÕ¹[J].ҽѧÑо¿ÓëÕ½´´É˾ÈÖÎ(ÔҽѧÑо¿Éúѧ±¨),2022,24(1):54.[doi:10.3969/j.issn.1672-271X.2022.01.012]
¡¡FENG Jing,WEI Juan,WANG Fang-yu.Progress in medical treatment of abdominal and pelvic abscess in Crohn¡¯s disease[J].JOURNAL OF MEDICALRESEARCH ¡ªCOMBAT TRAUMA CARE,2022,24(4):54.[doi:10.3969/j.issn.1672-271X.2022.01.012]